Halozyme Reports First Quarter 2019 Results

Go back to Halozyme Reports First Quarter 2019 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 130.91 -0.27 (0.21%)
Previous Close $131.18    52 Week High $18.39 
Open $132.66    52 Week Low $6.96 
Day High $134.00    P/E N/A 
Day Low $130.31    EPS $-0.58 
Volume 1,402,422